BR112014019171A8 - Composições intranasais de dexdetomida e seus métodos de uso - Google Patents
Composições intranasais de dexdetomida e seus métodos de usoInfo
- Publication number
- BR112014019171A8 BR112014019171A8 BR112014019171A BR112014019171A BR112014019171A8 BR 112014019171 A8 BR112014019171 A8 BR 112014019171A8 BR 112014019171 A BR112014019171 A BR 112014019171A BR 112014019171 A BR112014019171 A BR 112014019171A BR 112014019171 A8 BR112014019171 A8 BR 112014019171A8
- Authority
- BR
- Brazil
- Prior art keywords
- methods
- dexdetomide
- intranasal compositions
- intranasal
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
- A61M11/02—Sprayers or atomisers specially adapted for therapeutic purposes operated by air or other gas pressure applied to the liquid or other product to be sprayed or atomised
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/0007—Special media to be introduced, removed or treated introduced into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/04—Liquids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/06—Head
- A61M2210/0618—Nose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Dispersion Chemistry (AREA)
- Pain & Pain Management (AREA)
- Otolaryngology (AREA)
- Anesthesiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
COMPOSIÇÕES INTRANASAIS DE DEXMEDETOMIDINA E SEUS MÉTODOS DE USO. A presente invenção provê formulações intranasais compreendendo dexmedetomidina, ou um sal farmaceuticamente aceitável da mesma, e usos da mesma.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161569255P | 2011-12-11 | 2011-12-11 | |
PCT/US2012/068988 WO2013090278A2 (en) | 2011-12-11 | 2012-12-11 | Intranasal dexmedetomidine compositions and methods of use thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
BR112014019171A2 BR112014019171A2 (pt) | 2017-06-20 |
BR112014019171A8 true BR112014019171A8 (pt) | 2017-07-11 |
Family
ID=48613351
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112014019171A BR112014019171A8 (pt) | 2011-12-11 | 2012-12-11 | Composições intranasais de dexdetomida e seus métodos de uso |
Country Status (21)
Country | Link |
---|---|
US (2) | US9795559B2 (pt) |
EP (2) | EP2787970B1 (pt) |
JP (2) | JP6268100B2 (pt) |
KR (1) | KR102190009B1 (pt) |
CN (1) | CN104470516A (pt) |
AU (2) | AU2012352528B9 (pt) |
BR (1) | BR112014019171A8 (pt) |
CA (1) | CA2858721C (pt) |
CL (1) | CL2014001515A1 (pt) |
CO (1) | CO7000773A2 (pt) |
CR (1) | CR20140318A (pt) |
DO (1) | DOP2014000123A (pt) |
EC (1) | ECSP14007644A (pt) |
HK (1) | HK1203049A1 (pt) |
IL (1) | IL232977B (pt) |
MX (1) | MX367286B (pt) |
PE (1) | PE20142314A1 (pt) |
PH (1) | PH12014501273A1 (pt) |
RU (1) | RU2692245C2 (pt) |
SG (2) | SG10201604653TA (pt) |
WO (1) | WO2013090278A2 (pt) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112012031720A2 (pt) | 2010-06-16 | 2016-12-06 | Cargill Inc | composições a base de amido para substituição por látex |
BR112014019171A8 (pt) * | 2011-12-11 | 2017-07-11 | Recro Pharma Inc | Composições intranasais de dexdetomida e seus métodos de uso |
WO2015044782A2 (en) * | 2013-09-24 | 2015-04-02 | Shin Nippon Biomedical Laboratories, Ltd. | Intranasal dhe for the treatment of headache |
CN105764494A (zh) | 2013-10-07 | 2016-07-13 | 帝国制药美国公司 | 右旋美托咪啶经皮递送装置及其使用方法 |
KR101881791B1 (ko) * | 2013-10-07 | 2018-07-25 | 테이코쿠 팔마 유에스에이, 인코포레이티드 | 비진정성 덱스메데토미딘 경피 조성물을 사용하여 금단 증후군을 치료하기 위한 방법 및 조성물 |
RU2658463C2 (ru) | 2013-10-07 | 2018-06-21 | ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. | Способы и композиции для лечения синдрома дефицита внимания и гиперактивности, тревожности и бессонницы с применением трансдермальных композиций на основе дексмедетомидина |
JP6188933B2 (ja) | 2013-10-07 | 2017-08-30 | テイコク ファーマ ユーエスエー インコーポレーテッド | 非鎮静量のデクスメデトミジンの経皮送達用方法及び組成物 |
MA41689A (fr) * | 2014-10-15 | 2017-08-22 | Bioxcel Corp | Prévention ou traitement de troubles du sommeil au moyen d'une formulation de dexmédétomidine |
MX2019007923A (es) | 2016-12-31 | 2019-09-10 | Bioxcel Therapeutics Inc | Uso de dexmedetomidina sublingual para el tratamiento de la agitacion. |
CN114983979A (zh) * | 2018-06-27 | 2022-09-02 | 比奥克斯塞尔医疗股份有限公司 | 含右美托咪定的膜制剂及其制造方法 |
CN109620802A (zh) * | 2018-12-05 | 2019-04-16 | 杜皓 | 一种麻醉用鼻喷剂及其制备方法 |
CN111481506B (zh) * | 2019-01-25 | 2023-01-24 | 江苏恒瑞医药股份有限公司 | 一种包含经鼻给药的右美托咪定组合物的药物制品 |
CN112138250B (zh) * | 2019-06-28 | 2023-04-14 | 四川普锐特药业有限公司 | 保持给药均一度的药物流体分配器及右美托咪定鼻喷器 |
CN112107544A (zh) * | 2019-06-28 | 2020-12-22 | 四川普锐特药业有限公司 | 右美托咪定鼻喷剂、其制备方法及应用 |
CN114375191A (zh) | 2019-07-19 | 2022-04-19 | 比奥克斯塞尔医疗股份有限公司 | 非镇静的右美托咪定治疗方案 |
CN113827590A (zh) * | 2020-06-08 | 2021-12-24 | 四川普锐特药业有限公司 | 右美托咪定在助眠药物制备中的应用 |
TW202241416A (zh) * | 2021-01-04 | 2022-11-01 | 美商百歐克斯賽爾治療公司 | 右美托咪啶(dexmedetomidine)治療方案 |
CN115137699B (zh) * | 2021-03-29 | 2024-05-03 | 四川普锐特药业有限公司 | 一种增效防腐的右美托咪定鼻喷剂 |
CN113876776A (zh) * | 2021-11-04 | 2022-01-04 | 江苏大学附属医院 | 一种复方鼻喷镇痛药剂及其制备方法 |
US11806334B1 (en) | 2023-01-12 | 2023-11-07 | Bioxcel Therapeutics, Inc. | Non-sedating dexmedetomidine treatment regimens |
Family Cites Families (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2206880B (en) | 1987-07-16 | 1991-04-24 | Farmos Oy | Optical isomers of an imidazole derivative |
US5124157A (en) | 1989-08-18 | 1992-06-23 | Cygnus Therapeutic Systems | Method and device for administering dexmedetomidine transdermally |
US5217718A (en) | 1989-08-18 | 1993-06-08 | Cygnus Therapeutic Systems | Method and device for administering dexmedetomidine transdermally |
FI894911A0 (fi) | 1989-10-17 | 1989-10-17 | Farmos Oy | En terapeutiskt vaerdefull foerening. |
DE122007000103I1 (de) | 1990-12-05 | 2008-04-03 | Gen Hospital Corp | Verwendung von NO zur Behandlung der persistenten pulmonalen Hypertonie des Neugeborenen |
GB9111732D0 (en) | 1991-05-31 | 1991-07-24 | Orion Yhtymae Oy | The use of certain salts of medetomidine and its optically active enantiomers to regulate the rate of transdermal administration of the drugs |
US5571840A (en) | 1993-06-22 | 1996-11-05 | The Regents Of The University Of Michigan | Method for treating central nervous system ischemia |
GB2281206A (en) | 1993-08-25 | 1995-03-01 | Orion Yhtymae Oy | Use of dexmedetomidine |
US5713907A (en) | 1995-07-20 | 1998-02-03 | Endotex Interventional Systems, Inc. | Apparatus and method for dilating a lumen and for inserting an intraluminal graft |
GB9520150D0 (en) | 1995-10-03 | 1995-12-06 | Orion Yhtymae Oy | New imidazole derivatives |
CA2257172C (en) | 1996-05-29 | 2005-04-12 | Orion Corporation | Dissolvable oxides for biological applications |
US20050281752A1 (en) | 1997-10-01 | 2005-12-22 | Dugger Harry A Iii | Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system |
US20030077227A1 (en) | 1997-10-01 | 2003-04-24 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system |
DE19749724A1 (de) | 1997-11-11 | 1999-06-10 | Gruenenthal Gmbh | Verwendung einer Kombination aus Opioid und alpha-adrenergem Agonisten in Schmerzmitteln |
AR015744A1 (es) | 1998-04-01 | 2001-05-16 | Orion Corp | Uso de dexmedetomidina para sedacion en terapia intensiva |
US6716867B1 (en) | 1998-04-01 | 2004-04-06 | Orion Corporation | Use of dexmedetomidine for ICU sedation |
US7001609B1 (en) | 1998-10-02 | 2006-02-21 | Regents Of The University Of Minnesota | Mucosal originated drug delivery systems and animal applications |
ATE291907T1 (de) | 1998-10-20 | 2005-04-15 | Omeros Corp | Spülende lösung und methoden zur hemmung von schmerzen und entzündungen |
GB9913677D0 (en) | 1999-06-11 | 1999-08-11 | Imperial College | Formulation |
US20040115133A1 (en) * | 2000-05-10 | 2004-06-17 | Wermeling Daniel P. | Intranasal opioid compositions |
GB0029111D0 (en) * | 2000-11-29 | 2001-01-10 | Novartis Ag | Organic compounds |
AUPR184500A0 (en) | 2000-12-01 | 2001-01-04 | Drug Delivery Solutions Pty Ltd | Dispensing device |
US6582457B2 (en) | 2001-02-15 | 2003-06-24 | Radiant Medical, Inc. | Method of controlling body temperature while reducing shivering |
US20030022926A1 (en) | 2001-05-07 | 2003-01-30 | Lavand'homme Patricia | Method for treating neuropathic pain and pharmaceutical preparation therefor |
FR2834212B1 (fr) | 2001-12-27 | 2004-07-09 | Besins Int Belgique | Utilisation d'une poudre a liberation immediate dans des compositions pharmaceutiques et nutraceutiques |
IL147921A0 (en) | 2002-01-31 | 2002-08-14 | Abdulrazik Mohammad | A method for treating central nervous system disorders by ocular dosing |
US6864271B2 (en) | 2002-11-12 | 2005-03-08 | The Foundation For The Lsu Health Sciences Center | Synergistic combinations including N-acylated 4-hydroxyphenylamine derivatives |
EP1581245A2 (en) * | 2002-12-17 | 2005-10-05 | Nastech Pharmaceutical Company Inc. | Compositions and methods for enhanced mucosal delivery of y2 receptor-binding peptides and methods for treating and preventing obesity |
US7439241B2 (en) | 2003-05-27 | 2008-10-21 | Galderma Laboratories, Inc. | Compounds, formulations, and methods for treating or preventing rosacea |
US20050058696A1 (en) | 2003-09-12 | 2005-03-17 | Allergan, Inc. | Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions |
WO2006105205A1 (en) | 2005-03-29 | 2006-10-05 | University Of Kentucky Research Foundation | Sublingual spray for the treatment of pain |
US8481583B2 (en) | 2006-02-13 | 2013-07-09 | Orient Pharma (Samoa) Co., Ltd. | Combination of alpha-2 receptor agonist (clonidin) and anti-muscarinic agent (oxybutynin) for the treatment of sialorrhoea |
GB0611241D0 (en) | 2006-06-07 | 2006-07-19 | Daniolabs Ltd | The treatment of increased sebum production |
US20080021074A1 (en) | 2006-06-29 | 2008-01-24 | Questcor Pharmaceuticals, Inc. | Pharmaceutical Compositions and Related Methods of Treatment |
TW200824693A (en) * | 2006-08-28 | 2008-06-16 | Jazz Pharmaceuticals Inc | Pharmaceutical compositions of clonazepam and methods of use thereof |
CN101057830A (zh) | 2007-05-10 | 2007-10-24 | 北京天川军威医药技术开发有限公司 | 盐酸纳洛酮舌下喷雾给药系统或组合物及其制备方法 |
JP2011507895A (ja) | 2007-12-21 | 2011-03-10 | シェーリング−プラウ ヘルスケア プロダクツ,インコーポレイテッド | オキシメタゾリンの増強された光安定化 |
RU2572692C2 (ru) * | 2009-05-15 | 2016-01-20 | Рекро Фарма, Инк. | Сублингвальные композиции дексмедетомидина и способы их применения |
SG10201406930UA (en) * | 2009-07-27 | 2014-11-27 | Nocicepta Llc | Methods For Treatment Of Pain |
NZ601195A (en) * | 2010-01-08 | 2015-02-27 | Recro Pharma Inc | Topical transdermal dexmedetomidine compositions and methods of use thereof |
BR112014019171A8 (pt) * | 2011-12-11 | 2017-07-11 | Recro Pharma Inc | Composições intranasais de dexdetomida e seus métodos de uso |
-
2012
- 2012-12-11 BR BR112014019171A patent/BR112014019171A8/pt not_active Application Discontinuation
- 2012-12-11 JP JP2014546186A patent/JP6268100B2/ja active Active
- 2012-12-11 SG SG10201604653TA patent/SG10201604653TA/en unknown
- 2012-12-11 CN CN201280067920.4A patent/CN104470516A/zh active Pending
- 2012-12-11 EP EP12857098.3A patent/EP2787970B1/en active Active
- 2012-12-11 AU AU2012352528A patent/AU2012352528B9/en active Active
- 2012-12-11 WO PCT/US2012/068988 patent/WO2013090278A2/en active Application Filing
- 2012-12-11 RU RU2014128343A patent/RU2692245C2/ru active
- 2012-12-11 KR KR1020147017624A patent/KR102190009B1/ko active IP Right Grant
- 2012-12-11 MX MX2014006961A patent/MX367286B/es active IP Right Grant
- 2012-12-11 US US13/711,407 patent/US9795559B2/en active Active
- 2012-12-11 SG SG11201403094TA patent/SG11201403094TA/en unknown
- 2012-12-11 EP EP18161834.9A patent/EP3406247A1/en not_active Withdrawn
- 2012-12-11 PE PE2014000924A patent/PE20142314A1/es not_active Application Discontinuation
- 2012-12-11 CA CA2858721A patent/CA2858721C/en active Active
-
2014
- 2014-06-05 PH PH12014501273A patent/PH12014501273A1/en unknown
- 2014-06-05 IL IL232977A patent/IL232977B/en active IP Right Grant
- 2014-06-09 DO DO2014000123A patent/DOP2014000123A/es unknown
- 2014-06-09 CL CL2014001515A patent/CL2014001515A1/es unknown
- 2014-07-02 EC ECIEPI20147644A patent/ECSP14007644A/es unknown
- 2014-07-03 CR CR20140318A patent/CR20140318A/es unknown
- 2014-07-03 CO CO14143289A patent/CO7000773A2/es unknown
-
2015
- 2015-04-13 HK HK15103572.3A patent/HK1203049A1/xx unknown
-
2017
- 2017-09-08 JP JP2017172633A patent/JP6505177B2/ja not_active Expired - Fee Related
- 2017-09-12 US US15/702,319 patent/US10682311B2/en active Active
-
2018
- 2018-01-24 AU AU2018200591A patent/AU2018200591B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112014019171A8 (pt) | Composições intranasais de dexdetomida e seus métodos de uso | |
CY1121843T1 (el) | Σκευασματα ετανερσεπτης σταθεροποιημενα με ιοντα μαγνησιου | |
CY1122853T1 (el) | Σταθερα σκευασματα λινακλοτιδης | |
BR112015010663A8 (pt) | formas de dosagem oral de liberação sustentada, e uso de ruxolitinib ou de sal farmaceuticamente aceitável do mesmo | |
BR112014014769A2 (pt) | Composto, composição farmacêutica, e, uso de um composto ou sal. | |
BR112015003376A2 (pt) | composto ou sal farmaceuticamente aceitável do mesmo , composição farmacêutica e usos de quantidade eficiente | |
EA201400838A1 (ru) | ЗАМЕЩЕННЫЕ АМИДИНОМ β-ЛАКТАМЫ, ИХ ПОЛУЧЕНИЕ И ПРИМЕНЕНИЕ В КАЧЕСТВЕ АНТИБАКТЕРИАЛЬНЫХ СРЕДСТВ | |
TR201813877T4 (tr) | Spi̇nal müsküler atrofi̇ni̇n tedavi̇ edi̇lmesi̇ne yöneli̇k bi̇leşi̇kler. | |
CO6741203A2 (es) | Derivados de biciclo[3,2,1]octilamida y sus usos | |
BR112013000607A2 (pt) | 5-cloro-4-hidroxi-1-metil-2-oxo-n-fenil-1,2-di-hidroquinolina-3-carboxamida, os sais e suas utilizações | |
AR081681A1 (es) | METODOS Y COMPOSICIONES PARA LA ADMINISTRACION INTRATECAL DE b-GALACTOCEREBROSIDASA | |
PL2768937T3 (pl) | Preparaty, ich zastosowanie jako środków do mycia naczyń lub do wytwarzania środków do mycia naczyń i ich wytwarzanie | |
UY34350A (es) | Derivados de pirazolquinolinona, su preparación y su uso terapéutico. | |
IN2014DN10670A (pt) | ||
BR112014025041B8 (pt) | Composição farmacêutica | |
BR112014008555A2 (pt) | r(+)-n-formil-propargil-aminoindano | |
BR112014002845A2 (pt) | composto, sal farmaceuticamente aceitável, composição farmacêutica, e, uso de um composto | |
BR112014030720A8 (pt) | composto, composição farmacêutica e usos de inibidores de fbx03 | |
BR112015012443A2 (pt) | composição de limpeza, método de limpeza do corpo humano, uso da composição e método para prover limpeza | |
BR112013023575A2 (pt) | derivado de octaidrotienoquinolina, composição farmacêutica compreendendo o derivado, e uso destes | |
WO2012138731A3 (en) | Activated nucleoside analog conjugates and methods of use thereof | |
UA109804C2 (xx) | 2-метоксипіридин-4-ільні похідні | |
BR112019000988A2 (pt) | derivado de triazolopirazinona útil como inibidor de pde1 humana | |
CY1118277T1 (el) | Σταθερη φαρμακοτεχνικη μορφη πεξιγανανης | |
WO2012116992A3 (en) | Oral use of a composition comprising steviol or isosteviol |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |